MIDDLE EAST
EGYPT
Global > Middle East >
Egypt
Market Information
Egypt’s healthcare expenditure per capita is expected to be US$16.64bn by 2024.
Market Trend: The healthcare insurance market in Egypt is anticipated to expand, progressing from $5.67 billion in 2022 to $11.39 billion by 2030, exhibiting a Compound Annual Growth Rate (CAGR) of 9.1% between 2022 and 2030. In 2019, Egypt's healthcare spending constituted 4.74% of the GDP, equating to $150 per individual.
Egypt’s medical equipment market amounts to $3.0 billion in 2022, with an anticipated growth rate exceeding 7% over the period from 2022 to 2027.
The Health Sciences Authority (HSA) was formed in 2001 when voluntary registration was introduced. HSA regulates medical devices including IVDs under the Health Products Act 2007. All products are approved by the Medical Device Branch of HSA before it can be supplied in Singapore.
Medical Device Regulation
Central Administration for Pharmaceutical Affairs (CAPA), under the MOH.
Classification, Fees, Timeline
.png)
.png)
Product Registration Routes
Class I, IIa, IIb, III
Regular Track
Fast Track
Useful Information
Validity of License: 10 years.
License transfer: Not possible.
Importer and Distributor: Local License Holder, on behalf of the product owner, is responsible to appoint Importers and Distributors.
هل تحتاج إلى مزيد من التفاصيل؟.
نحن هنا للمساعدة. اتصل بنا على منصة ATTOPOLIS.
